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Background
Signalling by NO/cGMP is significant for regulation of
cardiovascular and renal function.
Results
For the functional analysis of cGMP signalling, transgenic
murine mutants were used. cGKI signalling pathways
include interaction of the cGKIb-isozyme with the inosi-
tol 1,4,5-trisphosphate receptor I (IP3RI) associated pro-
tein cGMP kinase substrate (IRAG). NO/cGMP and
ANP/cGMP-dependent relaxation of aortic smooth mus-
cle was strongly affected in IRAG-deficient mice. NO/
ANP-dependent inhibition of intracellular calcium
release was suppressed in IRAG-deficient vascular
smooth muscle cells (VSMC). Furthermore, reduction of
store operated calcium entry by cGMP was affected in
IRAG-KO VSMC. Basal mean arterial blood pressure,
heart rate and activity were not changed in IRAG knock-
out mice. However, under pathophysiological conditions
like sepsis (induced by E. coli lipopolysaccharide applica-
tion) IRAG knockout mice were resistant to blood pres-
sure reduction.
Conclusion
These results suggested that cGKI/IRAG signalling is a
predominant signal transduction pathway of NO/ANP/
cGMP which may be involved in vascular diseases
including pathophysiological modulation of blood pres-
sure. Further results provided evidence that cGMP sig-
nalling is essential for prevention of renal diseases
suppressing interstitial fibrosis.
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